Guideline on treating community-acquired pneumonia with Chinese patent medicines.
Pharmacol Res
; 196: 106919, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37722517
Amygdalin (PubChem CID: 656516); Chinese patent medicines; Clinical practice guideline; Community-acquired pneumonia; Forsythoside A (PubChem CID: 5281773); GRADE; Ginsenoside Rg3 (PubChem CID: 9918693); Licochalcone A (PubChem CID: 5318998); Ligustilide (PubChem CID: 5319022); Luteolin (PubChem CID: 5280445); Quercetin (PubChem CID: 5280343); Resveratrol (PubChem CID: 445154); Saikosaponin A (PubChem CID: 167928); Skullcap (PubChem CID: 156595888)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
/
Qualitative_research
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands